Phase III study to evaluate patient’s preference of...

  • Main
  • 2020 / 06
  • Phase III study to evaluate patient’s preference of...
European Journal of Cancer Care 2020 / 06

Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2‐positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012‐07)

Ciruelos, Eva M., Montaño, Alvaro, Rodríguez, César A., González‐Flores, Encarnación, Lluch, Ana, Garrigós, Laia, Quiroga, Vanesa, Antón, Antonio, Malón, Diego, Chacón, Jose I., Velasco, Mo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
European Journal of Cancer Care
DOI:
10.1111/ecc.13253
Date:
June, 2020
File:
PDF, 493 KB
2020
Conversion to is in progress
Conversion to is failed